Devyani-International-Limited-IPO-elite

Devyani International Ltd IPO details – Date, Price, Size, Allotment Status, Subscription

IPO-Note Devyani International Limited Rs-86-Rs90per Equity share Recommendation: Listing Gain   Company Profile: – Devyani International Limited is the largest franchisee of Yum Brands in India and is amongthe largest chain operators of quick service restaurants (“QSR”) in India on a non-exclusive basis.Yum! Brands Inc. operates brands such as KFC, Pizza Hut and Taco Bell and…

morning-outlook-img1

Morning Outlook 4th August 2021

NIFTY: The Nifty opened at 15951.55 with a gap up of 66 points. The index recorded its intraday low at 15914.35 within the first 5 minutes of trading and then started moving upside. The rally continued for the whole day and prices have recorded its intraday high at 16146.90 and finally closed at 16130.75. Almost…

Market-View-Feature-Image

Market View 4th August 2021

View on market: Stay Cautious, be with quality business: Asian stocks were off to a cautious start Wednesday as China’s clampdown on its technology giants and the spread of the delta Covid-19 strain subdue sentiment.Benchmarks edged lower in Japan, were SoftBank Group Corp. declined after a potential block of its $40 billion sale of Arm…

Krsnaa-Diagnostic-Limited-IPO-Elite

KRSNAA DIAGNOSTICS LIMITED IPO details – Date, Price, Size, Allotment Status, Subscription

IPO-Note KRSNAA DIAGNOSTICS LIMITED Rs.933-Rs.954per Equity share Recommendation: Listing Gains Company Profile: – Krsnaa Diagnostics is one of the largest Diagnostic service provider that provides technology enabled diagnostic services like Pathology laboratory, Tele-radiology services and Imaging services to Private and Public hospitals, community healthCentre at affordable prices.Company follows two segments diagnostic imaging/radiology services and Pathology…

Windlas-Biotech-Limited-IPO-Elite

Windlas Biotech Limited IPO details – Date, Price, Size, Allotment Status, Subscription

IPO-Note Windlas Biotech Limited Rs-448-Rs460per Equity share Recommendation: Listing Gain   Company Profile: – Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations contract development andmanufacturing organization (“CDMO”) industry in India in terms of revenue. The company has three distinct strategic business verticals: (i) CDMO Services and Products; (ii) DomesticTrade Generics…